Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis-Reference-Cited by-同舟云学术

Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis

Published:2021-10 Issue: Volume:111 Page:138-147
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Fu Liang^ORCID,Weng Taoping,Sun Feng,Zhang Peize,Li Hui,Li Yang,Yang Qianting,Cai Yi,Zhang Xilin,Liang Hancheng,Chen Xinchun,Wang Zhaoqin,Liu Lei,Zhang Wenhong,Deng Guofang

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference38 articles.

1. Evaluation of Sensititre® MYCOTB Panel for the Susceptibility Testing of Mycobacterium tuberculosis to First and Second Lines Anti-Tuberculosis Drugs;Abdelrahman;Clin Med Diagn,2016

2. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis;Ahmad;LANCET,2018

3. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients;Atif;BMC Infect Dis,2017

4. What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?;Bastard;Int J Tuberc Lung Dis,2019

5. Real-world data: towards achieving the achievable in cancer care;Booth;Nat Rev Clin Oncol,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Faster, higher, stronger: the evolution of clinical perspectives on pan-TB;One Health & Implementation Research;2024-06-27

2. Relapse after treatment with standardized all-oral short regimens for rifampicin-resistant tuberculosis (RR-TB): A systematic review and meta-analysis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-05

3. Clinical Efficacy and Safety of Clofazimine in Treatment Regimens for Drug Resistant Tuberculosis (Meta-Analysis);Tuberculosis and Lung Diseases;2024-04-30

4. Study of Culture Conversion in Drug-Resistant Pulmonary Tuberculosis on All-Oral Longer Regimen at IGIMS, Patna;Journal of Pharmacy and Bioallied Sciences;2024-04

5. Evaluation of Sulfasalazine as an Adjunctive Therapy in Treating Pulmonary Pre-XDR-TB: Efficacy, Safety, and Treatment Implication;Infection and Drug Resistance;2024-02